Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the basis of partnerships with big pharma and lead to the formation of new biotech companies — all focused on common diseases.
The post Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases appeared first on MedCity News.
